Casein-related anaphylaxis after use of an Everlast kickboxing glove - 06/01/15
Disclosure of potential conflict of interest: D. I. Scheer has board memberships with and has received travel expenses from Achillion Pharmaceuticals, Aegerion Pharmaceuticals, Tengion, Axerion Therapeutics, and Optherion; has consultant arrangements with and has stock/stock options with Angiochem and Nektar Therapeutics; and is employed by Scheer & Company and receives stock/stock options as part of his compensation. R. Gruchalla is a consultant for the US Food and Drug Administration and has received research support from the National Institutes of Health. H. A. Sampson has received research support from the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, and Food Allergy Research and Education; is the chair of the PhARF Award review committee; has consultant arrangements from Allertein Therapeutics, Regeneron, and the Danone Research Institute; and has received payment for lectures from Thermo Fisher Scientific, UCB, and Pfizer. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 135 - N° 1
P. 269-271 - janvier 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?